TNF Polymorphisms in Patients with Behçet Disease: A Meta-analysis

Archives of Medical Research

Volumn 41, Issue 2, 2010, Pages 142-146

  Touma, Zahi ^a   Farra, Chantal ^b   Hamdan, Ayad ^c   Shamseddeen, Wael ^d   Uthman, Imad ^b   Hourani, Hala ^e   Arayssi, Thurayya ^f  

^a UNIVERSITY OF TORONTO   (Canada)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^c HARVARD MEDICAL SCHOOL   (United States)

^d ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^e Chronic Care Center Hazmieh   (Lebanon)

^f WEILL CORNELL MEDICAL COLLEGE   (Qatar)

Author keywords

Beh et's disease; Meta analysis; Middle East; Polymorphisms; Tumor necrosis factor alpha

Indexed keywords

TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BEHCET DISEASE; DISEASE PREDISPOSITION; ETHNIC GROUP; GENE FREQUENCY; GENE LOCATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; MIDDLE EAST; PROMOTER REGION;

ADOLESCENT; ADULT; BEHCET SYNDROME; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; ETHNIC GROUPS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 77952891804     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2010.02.002     Document Type: Article

References (25)

1. Arayssi T., Hamdan A. New insights into the pathogenesis and therapy of Behcet's disease. Curr Opinion Pharmacol 2004, 4:183-188.
2. Akman A., Sallakci N., Coskun M., et al. TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behcet's disease. Br J Dermatol 2006, 155:350-356.
3. Lee E.B., Kim J.Y., Lee Y.J., et al. TNF and TNF receptor polymorphisms in Korean Behcet's disease patients. Hum Immunol 2003, 64:614-620.
4. Gul A., Hajeer A.H., Worthington J., et al. Linkage mapping of a novel susceptibility locus for Behcet's disease to chromosome 6p22-23. Arthritis Rheum 2001, 44:2693-2696.
5. Arayssi T., Hamra R., Homeidan F., et al. The efficacy of a single dose of infliximab in the treatment of Behcet's disease uveitis. Clin Exp Rheumatol 2005, 23:427.
6. Sfikakis P.P., Markomichelakis N., Alpsoy E., et al. Anti-TNF therapy in the management of Behcet's disease-review and basis for recommendations. Rheumatology (Oxford) 2007, 46:736-741.
7. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
8. Arayssi T.K., Hamdan A.R., Touma Z., et al. TNF polymorphisms in Lebanese patients with Behcet's disease. Clin Exp Rheumatol 2008, 26(suppl):130-131.
9. Verity D.H., Wallace G.R., Vaughan R.W., et al. HLA and tumour necrosis factor (TNF) polymorphisms in ocular Behcet's disease. Tissue Antigens 1999, 54:264-272.
10. Chang H.K., Jang W.C., Park S.B., et al. The novel -G646A polymorphism of the TNF alpha promoter is associated with the HLA-B51 allele in Korean patients with Behcet's disease. Scand J Rheumatol 2007, 36:216-221.
11. Alayli G., Aydin F., Coban A.Y., et al. T helper 1 type cytokines polymorphisms: association with susceptibility to Behcet's disease. Clin Rheumatol 2007, 26:1299-1305.
12. Kamoun M., Chelbi H., Houman M.H., et al. Tumor necrosis factor gene polymorphisms in Tunisian patients with Behcet's disease. Hum Immunol 2007, 68:201-205.
13. Park K., Kim N., Nam J., et al. Association of TNFA promoter region haplotype in Behcet's Disease. J Korean Med Sci 2006, 21:596-601.
14. Ates A., Kinikli G., Duzgun N., et al. Lack of association of tumor necrosis factor-alpha gene polymorphisms with disease susceptibility and severity in Behcet's disease. Rheumatol Int 2006, 26:348-353.
15. Duymaz-Tozkir J., Gul A., Uyar F.A., et al. Tumour necrosis factor-alpha gene promoter region -308 and -376 G>A polymorphisms in Behcet's disease. Clin Exp Rheumatol 2003, 21(suppl):15-18.
16. Ahmad T., Wallace G.R., James T., et al. Mapping the HLA association in Behcet's disease: a role for tumor necrosis factor polymorphisms?. Arthritis Rheum 2003, 48:807-813.
17. Storz K., Loffler J., Koch S., et al. IL-6 receptor, IL-8 receptor and TNF-alpha238 (G/A) polymorphisms are not associated with Behcet's disease in patients of German or Turkish origin. Clin Exp Rheumatol 2008, 26(suppl):103-106.
18. Akman A., Sallakci N., Kacaroglu H., et al. Relationship between periodontal findings and the TNF-alpha gene 1031T/C polymorphism in Turkish patients with Behcet's disease. J Eur Acad of Dermatol Venereol 2008, 22:950-957.
19. Khanna D., Wu H., Park G., et al. Association of tumor necrosis factor alpha polymorphism, but not the shared epitope, with increased radiographic progression in a seropositive rheumatoid arthritis inception cohort. Arthritis Rheum 2006, 54:1105-1116.
20. Negoro K., Kinouchi Y., Hiwatashi N., et al. Crohn's disease is associated with novel polymorphisms in the 5'-flanking region of the tumor necrosis factor gene. Gastroenterology 1999, 117:1062-1068.
21. Kamizono S., Hiromatsu Y., Seki N., et al. A polymorphism of the 5' flanking region of tumour necrosis factor alpha gene is associated with thyroid-associated ophthalmopathy in Japanese. Clin Endocrinol (Oxf) 2000, 52:759-764.
22. Hajeer A.H., Hutchinson I.V. TNF-alpha gene polymorphism: clinical and biological implications. Microsc Res Tech 2000, 50:216-228.
23. Reich K., Huffmeier U., Konig I.R., et al. TNF polymorphisms in psoriasis: association of psoriatic arthritis with the promoter polymorphism TNF*-857 independent of the PSORS1 risk allele. Arthritis Rheum 2007, 56:2056-2064.
24. Kuo N.W., Lympany P.A., Menezo V., et al. TNF-857T, a genetic risk marker for acute anterior uveitis. Invest Ophthalmol Vis Sci 2005, 46:1565-1571.
25. Kang C.P., Lee K.W., Yoo D.H., et al. The influence of a polymorphism at position -857 of the tumour necrosis factor alpha gene on clinical response to etanercept therapy in rheumatoid arthritis. Rheumatology (Oxford) 2005, 44:547-552.